Timber Pharmaceuticals Inc

ASE:TMBR   3:59:50 PM EDT
0.26
+0.02 (+8.12%)
Earnings Announcements

Timber Pharmaceuticals Announces First Quarter 2022 Financial Results

Published: 05/12/2022 20:54 GMT
Timber Pharmaceuticals Inc (TMBR) - Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2022 Financial Results.
Timber Pharmaceuticals - Qtrly Loss per Share $0.05.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.